Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 85

Results For "STI"

6865 News Found

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
Policy | April 25, 2026

India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh

At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones


Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
Public Health | April 25, 2026

Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement

The summit brought together over 150 doctors, researchers, and practitioners worldwide


ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre
Hospitals | April 25, 2026

ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre

Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof


Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
Digitisation | April 25, 2026

Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform

AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable


India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
Public Health | April 25, 2026

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem

Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms


Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
Supply Chain | April 25, 2026

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region


New genomics clinic by Fortis Hospitals targets early disease detection
Healthcare | April 24, 2026

New genomics clinic by Fortis Hospitals targets early disease detection

New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care